APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azelastine Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Azelastine Drug Industry Growth and Trends Forecast to 2032

2 January 2026101 pages

Choose your research edition.

Industry ResearchAzelastine Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Azelastine Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Azelastine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azelastine Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Azelastine Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Azelastine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Azelastine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Azelastine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azelastine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azelastine Drug include Alkem Labs, Amneal Pharmaceuticals, Apotex, Hikma Pharmaceuticals, Perrigo, Viatris, Zhongsheng Pharma, Yunfeng Pharma and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Azelastine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Azelastine Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azelastine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azelastine Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Azelastine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Azelastine Drug Market by Company

Alkem Labs

Amneal Pharmaceuticals

Apotex

Hikma Pharmaceuticals

Perrigo

Viatris

Zhongsheng Pharma

Yunfeng Pharma

Sun Pharma

Jiangxi Zhenshiming Pharmaceutical

Azelastine Drug Segment by Type

Nasal Spray

Eye Drops

Other

Azelastine Drug Segment by Application

Hospital

Retail Pharmacy

Other

Azelastine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azelastine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azelastine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azelastine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azelastine Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Azelastine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Spray Table 2. Major Company of Eye Drops Table 3. Major Company of Other Table 4. Global Azelastine Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Azelastine Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Azelastine Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Azelastine Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Azelastine Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Azelastine Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Azelastine Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Azelastine Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Azelastine Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Azelastine Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Azelastine Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Azelastine Drug Industry Trends Table 26. Azelastine Drug Industry Drivers Table 27. Azelastine Drug Industry Opportunities and Challenges Table 28. Azelastine Drug Industry Restraints Table 29. Global Azelastine Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Azelastine Drug Revenue Market Share by Company (2021-2026) Table 31. Global Azelastine Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Azelastine Drug Sales Share by Company (2021-2026) Table 33. Global Azelastine Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Azelastine Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Azelastine Drug Major Company Production Sites and Headquarters Table 36. Global Azelastine Drug Company, Product Type & Application Table 37. Global Azelastine Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Azelastine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Azelastine Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Azelastine Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Azelastine Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Azelastine Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Azelastine Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Azelastine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Azelastine Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Azelastine Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Azelastine Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Azelastine Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Azelastine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Azelastine Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Azelastine Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Azelastine Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Azelastine Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Azelastine Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Azelastine Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Azelastine Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Azelastine Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Azelastine Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Azelastine Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Azelastine Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Alkem Labs Company Information Table 73. Alkem Labs Business Overview Table 74. Alkem Labs Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Alkem Labs Azelastine Drug Product Portfolio Table 76. Alkem Labs Recent Development Table 77. Amneal Pharmaceuticals Company Information Table 78. Amneal Pharmaceuticals Business Overview Table 79. Amneal Pharmaceuticals Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Amneal Pharmaceuticals Azelastine Drug Product Portfolio Table 81. Amneal Pharmaceuticals Recent Development Table 82. Apotex Company Information Table 83. Apotex Business Overview Table 84. Apotex Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Apotex Azelastine Drug Product Portfolio Table 86. Apotex Recent Development Table 87. Hikma Pharmaceuticals Company Information Table 88. Hikma Pharmaceuticals Business Overview Table 89. Hikma Pharmaceuticals Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hikma Pharmaceuticals Azelastine Drug Product Portfolio Table 91. Hikma Pharmaceuticals Recent Development Table 92. Perrigo Company Information Table 93. Perrigo Business Overview Table 94. Perrigo Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Perrigo Azelastine Drug Product Portfolio Table 96. Perrigo Recent Development Table 97. Viatris Company Information Table 98. Viatris Business Overview Table 99. Viatris Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Viatris Azelastine Drug Product Portfolio Table 101. Viatris Recent Development Table 102. Zhongsheng Pharma Company Information Table 103. Zhongsheng Pharma Business Overview Table 104. Zhongsheng Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Zhongsheng Pharma Azelastine Drug Product Portfolio Table 106. Zhongsheng Pharma Recent Development Table 107. Yunfeng Pharma Company Information Table 108. Yunfeng Pharma Business Overview Table 109. Yunfeng Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Yunfeng Pharma Azelastine Drug Product Portfolio Table 111. Yunfeng Pharma Recent Development Table 112. Sun Pharma Company Information Table 113. Sun Pharma Business Overview Table 114. Sun Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sun Pharma Azelastine Drug Product Portfolio Table 116. Sun Pharma Recent Development Table 117. Jiangxi Zhenshiming Pharmaceutical Company Information Table 118. Jiangxi Zhenshiming Pharmaceutical Business Overview Table 119. Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Product Portfolio Table 121. Jiangxi Zhenshiming Pharmaceutical Recent Development Table 122. North America Azelastine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Azelastine Drug Sales by Country (2021-2026) & (K Units) Table 124. North America Azelastine Drug Sales Market Share by Country (2021-2026) Table 125. North America Azelastine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Azelastine Drug Sales Market Share Forecast by Country (2027-2032) Table 127. North America Azelastine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Azelastine Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Azelastine Drug Market Share by Country (2021-2026) Table 130. North America Azelastine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Azelastine Drug Market Share Forecast by Country (2027-2032) Table 132. Europe Azelastine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Azelastine Drug Sales by Country (2021-2026) & (K Units) Table 134. Europe Azelastine Drug Sales Market Share by Country (2021-2026) Table 135. Europe Azelastine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Azelastine Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Azelastine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Azelastine Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Azelastine Drug Market Share by Country (2021-2026) Table 140. Europe Azelastine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Azelastine Drug Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Azelastine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Azelastine Drug Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Azelastine Drug Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Azelastine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Azelastine Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Azelastine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Azelastine Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Azelastine Drug Market Share by Country (2021-2026) Table 150. Asia-Pacific Azelastine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Azelastine Drug Market Share Forecast by Country (2027-2032) Table 152. Latin America Azelastine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Azelastine Drug Sales by Country (2021-2026) & (K Units) Table 154. Latin America Azelastine Drug Sales Market Share by Country (2021-2026) Table 155. Latin America Azelastine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Azelastine Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Azelastine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Azelastine Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Azelastine Drug Market Share by Country (2021-2026) Table 160. Latin America Azelastine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Azelastine Drug Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Azelastine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Azelastine Drug Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Azelastine Drug Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Azelastine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Azelastine Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Azelastine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Azelastine Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Azelastine Drug Market Share by Country (2021-2026) Table 170. Middle East and Africa Azelastine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Azelastine Drug Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Azelastine Drug Distributors List Table 175. Azelastine Drug Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Azelastine Drug Image Figure 2. Global Azelastine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azelastine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Azelastine Drug Sales (2021-2032) & (K Units) Figure 5. Nasal Spray Image Figure 6. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 7. Eye Drops Image Figure 8. Global Eye Drops Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Azelastine Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Azelastine Drug Market Share by Type 2025 VS 2032 Figure 13. North America Azelastine Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Azelastine Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Azelastine Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Azelastine Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Azelastine Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Azelastine Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Azelastine Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Azelastine Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Azelastine Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Azelastine Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Azelastine Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Azelastine Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Azelastine Drug Market Share by Application 2025 VS 2032 Figure 33. North America Azelastine Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Azelastine Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Azelastine Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Azelastine Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Azelastine Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Azelastine Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Azelastine Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Azelastine Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Azelastine Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Azelastine Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Azelastine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Azelastine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Azelastine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Azelastine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Azelastine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Azelastine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Azelastine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Azelastine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Azelastine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Azelastine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Azelastine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Azelastine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Azelastine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Azelastine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Azelastine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Azelastine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Azelastine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Azelastine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Azelastine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Azelastine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Azelastine Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Azelastine Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Eye Drops
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Alkem Labs
  • Amneal Pharmaceuticals
  • Apotex
  • Hikma Pharmaceuticals
  • Perrigo
  • Viatris
  • Zhongsheng Pharma
  • Yunfeng Pharma
  • Sun Pharma
  • Jiangxi Zhenshiming Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azelastine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Azelastine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Azelastine Drug Market by Type
  6. 1.3.1 Nasal Spray
  7. 1.3.2 Eye Drops
  8. 1.3.3 Other
  9. 1.4 Global Azelastine Drug Market Size by Type
  10. 1.4.1 Global Azelastine Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Azelastine Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Azelastine Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Azelastine Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Azelastine Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Azelastine Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Azelastine Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Azelastine Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Azelastine Drug Industry Trends
  2. 2.2 Azelastine Drug Industry Drivers
  3. 2.3 Azelastine Drug Industry Opportunities and Challenges
  4. 2.4 Azelastine Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Azelastine Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Azelastine Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Azelastine Drug Price (2021-2026)
  4. 3.4 Global Azelastine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azelastine Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Azelastine Drug Company, Product Type & Application
  7. 3.7 Global Azelastine Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azelastine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azelastine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azelastine Drug Tier 1, Tier 2, and Tier 3
4 Azelastine Drug Regional Status and Outlook
  1. 4.1 Global Azelastine Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Azelastine Drug Historic Market Size by Region
  3. 4.2.1 Global Azelastine Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Azelastine Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Azelastine Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Azelastine Drug Forecasted Market Size by Region
  7. 4.3.1 Global Azelastine Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Azelastine Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Azelastine Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azelastine Drug by Application
  1. 5.1 Azelastine Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Azelastine Drug Market Size by Application
  6. 5.2.1 Global Azelastine Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Azelastine Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Azelastine Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Azelastine Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Azelastine Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Azelastine Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Azelastine Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Azelastine Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alkem Labs
  2. 6.1.1 Alkem Labs Company Information
  3. 6.1.2 Alkem Labs Business Overview
  4. 6.1.3 Alkem Labs Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alkem Labs Azelastine Drug Product Portfolio
  6. 6.1.5 Alkem Labs Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Azelastine Drug Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Apotex
  14. 6.3.1 Apotex Company Information
  15. 6.3.2 Apotex Business Overview
  16. 6.3.3 Apotex Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apotex Azelastine Drug Product Portfolio
  18. 6.3.5 Apotex Recent Developments
  19. 6.4 Hikma Pharmaceuticals
  20. 6.4.1 Hikma Pharmaceuticals Company Information
  21. 6.4.2 Hikma Pharmaceuticals Business Overview
  22. 6.4.3 Hikma Pharmaceuticals Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma Pharmaceuticals Azelastine Drug Product Portfolio
  24. 6.4.5 Hikma Pharmaceuticals Recent Developments
  25. 6.5 Perrigo
  26. 6.5.1 Perrigo Company Information
  27. 6.5.2 Perrigo Business Overview
  28. 6.5.3 Perrigo Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Perrigo Azelastine Drug Product Portfolio
  30. 6.5.5 Perrigo Recent Developments
  31. 6.6 Viatris
  32. 6.6.1 Viatris Company Information
  33. 6.6.2 Viatris Business Overview
  34. 6.6.3 Viatris Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Viatris Azelastine Drug Product Portfolio
  36. 6.6.5 Viatris Recent Developments
  37. 6.7 Zhongsheng Pharma
  38. 6.7.1 Zhongsheng Pharma Company Information
  39. 6.7.2 Zhongsheng Pharma Business Overview
  40. 6.7.3 Zhongsheng Pharma Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zhongsheng Pharma Azelastine Drug Product Portfolio
  42. 6.7.5 Zhongsheng Pharma Recent Developments
  43. 6.8 Yunfeng Pharma
  44. 6.8.1 Yunfeng Pharma Company Information
  45. 6.8.2 Yunfeng Pharma Business Overview
  46. 6.8.3 Yunfeng Pharma Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yunfeng Pharma Azelastine Drug Product Portfolio
  48. 6.8.5 Yunfeng Pharma Recent Developments
  49. 6.9 Sun Pharma
  50. 6.9.1 Sun Pharma Company Information
  51. 6.9.2 Sun Pharma Business Overview
  52. 6.9.3 Sun Pharma Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharma Azelastine Drug Product Portfolio
  54. 6.9.5 Sun Pharma Recent Developments
  55. 6.10 Jiangxi Zhenshiming Pharmaceutical
  56. 6.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
  57. 6.10.2 Jiangxi Zhenshiming Pharmaceutical Business Overview
  58. 6.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Product Portfolio
  60. 6.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Azelastine Drug Sales by Country
  2. 7.1.1 North America Azelastine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Azelastine Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Azelastine Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Azelastine Drug Market Size by Country
  6. 7.2.1 North America Azelastine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Azelastine Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Azelastine Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Azelastine Drug Sales by Country
  2. 8.1.1 Europe Azelastine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Azelastine Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Azelastine Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Azelastine Drug Market Size by Country
  6. 8.2.1 Europe Azelastine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Azelastine Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Azelastine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Azelastine Drug Sales by Country
  2. 9.1.1 Asia-Pacific Azelastine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Azelastine Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Azelastine Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Azelastine Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Azelastine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Azelastine Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Azelastine Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Azelastine Drug Sales by Country
  2. 10.1.1 South America Azelastine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Azelastine Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Azelastine Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Azelastine Drug Market Size by Country
  6. 10.2.1 South America Azelastine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Azelastine Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Azelastine Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Azelastine Drug Sales by Country
  2. 11.1.1 Middle East and Africa Azelastine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Azelastine Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Azelastine Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Azelastine Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Azelastine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Azelastine Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Azelastine Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Azelastine Drug Value Chain Analysis
  2. 12.1.1 Azelastine Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Azelastine Drug Production Mode & Process
  7. 12.2 Azelastine Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Azelastine Drug Distributors
  10. 12.2.3 Azelastine Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst